- Home
- KALV vs YRD Comparison
KALV vs YRD Comparison
Compare KALV & YRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- YRD
- Stock Information
- Founded
- KALV N/A
- YRD 2012
- Country
- KALV United States
- YRD China
- Employees
- KALV N/A
- YRD N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- YRD Finance: Consumer Services
- Sector
- KALV Health Care
- YRD Finance
- Exchange
- KALV Nasdaq
- YRD Nasdaq
- Market Cap
- KALV 362.2M
- YRD 411.2M
- IPO Year
- KALV N/A
- YRD 2015
- Fundamental
- Price
- KALV $8.75
- YRD $5.17
- Analyst Decision
- KALV Strong Buy
- YRD
- Analyst Count
- KALV 7
- YRD 0
- Target Price
- KALV $27.00
- YRD N/A
- AVG Volume (30 Days)
- KALV 319.9K
- YRD 98.2K
- Earning Date
- KALV 03-10-2025
- YRD 11-20-2024
- Dividend Yield
- KALV N/A
- YRD 3.88%
- EPS Growth
- KALV N/A
- YRD N/A
- EPS
- KALV N/A
- YRD 2.95
- Revenue
- KALV N/A
- YRD $802,340,579.00
- Revenue This Year
- KALV N/A
- YRD N/A
- Revenue Next Year
- KALV N/A
- YRD N/A
- P/E Ratio
- KALV N/A
- YRD $1.67
- Revenue Growth
- KALV N/A
- YRD 19.51
- 52 Week Low
- KALV $7.30
- YRD $4.01
- 52 Week High
- KALV $16.88
- YRD $9.20
- Technical
- Relative Strength Index (RSI)
- KALV 51.87
- YRD 58.02
- Support Level
- KALV $7.30
- YRD $4.61
- Resistance Level
- KALV $9.16
- YRD $4.90
- Average True Range (ATR)
- KALV 0.41
- YRD 0.21
- MACD
- KALV 0.07
- YRD 0.04
- Stochastic Oscillator
- KALV 78.17
- YRD 77.52
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About YRD Yiren Digital Ltd.
Yiren Digital Ltd is an advanced, AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.